Works citing this work

2 works

Work: Nanoparticles in Clinical Trials: Analysis of Clinical Trials, FDA Approvals and Use for COVID-19 Vaccines

1. Emerging strategies to reduce the side effects of CAR-T cell therapy: focusing on gene editing and nanotechnology

   Jinxin Dong, Denis Nikolenko, Shuxrat Boymuradov +2

   ArticleCAR-T cell therapy researchClinical & Translational Oncology20261 citations

   ABIABI:AkademIndex/openalex/2026.article.000172

2. Nanoparticle-Based PCSK9 Inhibition in Viral Infections: Evaluating Clinical Limitations and Advancing Therapeutic Strategies

   Moeen F. Dababneh, Bahjat Alhasso, Abdulkareem Shareef +10

   ArticleLipoproteins and Cardiovascular HealthJournal of Pharmaceutical Innovation20260 citations

   ABIABI:AkademIndex/openalex/2026.article.013240